Position | Company | Period |
---|---|---|
Non-Executive Independent Chairman of the Board | Avadel Pharmaceuticals PLC | July 1, 2014 - May 9, 2019 |
Independent Director | Abercrombie & Fitch Co | Jan. 27, 2014 - June 1, 2017 |
Independent Director | Avadel Pharmaceuticals PLC | June 24, 2011 - July 1, 2014 |
Lead Independent Director | Abercrombie & Fitch Co | Feb. 23, 2010 - Jan. 27, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2017-09-14 | 2017-09-12 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
20,000
+22.2%
9.52190,360 USD |
20,000 +22.2% | 9.52 | 190,360 USD | |
2016-11-30 | 2016-11-29 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
10,000
+33.3%
10.85108,500 USD |
10,000 +33.3% | 10.85 | 108,500 USD | |
2016-09-06 | 2016-09-01 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
10,000
+2.0%
13.52135,190 USD |
10,000 +2.0% | 13.52 | 135,190 USD | |
2016-08-29 | 2016-08-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
9,122
+83.9%
13.67124,698 USD |
9,122 +83.9% | 13.67 | 124,698 USD | |
2016-08-29 | 2016-08-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
10,878
+inf%
13.83150,443 USD |
10,878 +inf% | 13.83 | 150,443 USD | |
2016-03-16 | 2016-03-14 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
100,000
+26.1%
10.391,039,400 USD |
100,000 +26.1% | 10.39 | 1,039,400 USD |